Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: Results of the United Kingdom Medical Research Council's 10th AML trial

British Journal of Haematology

Volumn 101, Issue 1, 1998, Pages 130-140

  Stevens, Richard F ^a   Hann, Ian M ^b   Wheatley, Keith ^c,d   Gray, Richard G ^c  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^d RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

Acute myeloid leukaemia; Bone marrow transplantation; Chemotherapy; Children; Improved outcome

Indexed keywords

AMSACRINE; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HLA MATCHING; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED KINGDOM;

ACUTE DISEASE; ADOLESCENT; AMSACRINE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID; MALE; MITOXANTRONE; PATIENT COMPLIANCE; RECURRENCE; REMISSION INDUCTION; SURVIVAL RATE; THIOGUANINE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0031958821     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00677.x     Document Type: Article

References (21)

1. Amadori, S., Testi, A.M., Aricò, M., Cumelli, A., Giuliano, M., Madon, E., Masera, G., Rondelli, R., Zanesco, L. & Mandelli, F. (1993) Prospective comparative study of bone marrow transplantation and postremission chemotherapy for childhood acute myelogenous leukemia. Journal of Clinical Oncology, 11, 1046-1054.
2. Béhar, C., Suciu, S., Benoit, Y., Robert, A., Vilmer, E., Boutard, P., Bertrand, Y., Lutz, P., Ferster, A., Tokaji, E., Manel, A.M., Solbu, G. & Otten, J. (1996) Mitoxantrone-containing regimen for treatment of childhood acute leukemia (AML) and analysis of prognostic factors: results of the EORTC Children Leukemia Cooperative Study 58872. Medical and Pediatric Oncology, 26, 173-179.
3. Burnett, A.K., Goldstone, A.H., Stevens, R.K. Hann. I.M., Gray, R.G., Rees, J.K.H. & Wheatley, K. (1998) The addition of autologous bone marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission significantly reduces the risk of relapse and prolongs survival. Lancet, in press.
4. Creutzig, U., Harbott, J., Sperling, C., Ritter, J., Zimmermann, M., Loffler, H., Riehm, H., Schellong, G. & Ludwig, W.D. (1996) Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of Study AML-BFM-87. Blood, 86, 3097-3108.
5. Creutzig, U., Ritter, J. & Zimmermann, M. (1993) Does cranial irradiation reduce the risk for bone marrow relapse in acute myelogenous leukemia? Unexpected results of the Childhood Acute Myelogenous Leukemia Study BFM-87. Journal of Clinical Oncology 11, 279-286.
6. Gray, R. & Wheatley, K. (1991) How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplantation, 7, (Suppl. 3), 9-12.
7. Hann, I.M. (1992) CNS-directed therapy in childhood acute lymphoblastic leukaemia. British Journal of Haematology. 82, 2-5.
8. Hann, I.M., Stevens, R.F., Goldstone, A.H., Rees, J.K.H., Wheatley, K., Gray, R.G. & Burnett, A.K. (1997) Randomised comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Blood. 89, 2311-2318.
9. Lie, O.E., Jonmundsson, G., Mellander, L., Slimes, M.A., Yssing, M. & Gustafsson, G. (1996) A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. British Journal of Haematology, 94, 82-88.
10. Lipshultz, S.E., Colan, S.D., Gelber, R.D., Perez-Atayde, A.R., Sallan, S.E. & Sanders, S.P. (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukaemia in childhood. New England Journal of Medicine, 324, 808-815.
11. Mantel, N. & Byar, D.B. (1974) Evaluation of response time data involving transient states: an illustration using heart-transplantation data. Journal of the American Statistical Association. 69, 81-86.
12. Michel, G., Gluckman, E., Blaise, D., Esperou-Bourdeau, H., Vermant, J.P., Kuenta, M., Bordigoni, P., Milpied, N., Ruble, H. & Thuret, I. (1992) Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osscuse. Journal of Clinical Oncology, 10, 1855-1869.
13. Nesbit, M.E., Buckley, J.D., Feig, S.A., Anderson, J.R., Lampkin, B., Bernstein, I.D., Kim, T.H., Piomelli, S., Kersey, J.H. & Coccia, P.F. (1994) Chemotherapy for induction of remission of childhood acute myeloid leukaemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group. Journal of Clinical Oncology. 12, 127-135.
14. Ravindranath, Y., Yeager, A.M., Chang, M.N., Steuber, C.P., Krischer, J., Graham Pole, J., Carroll, A., Inoue, S., Camitta, B. & Weinstein, H.J. (1996) Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. New England Journal of Medicine. 334, 1428-1434.
15. Rees, J.K., Gray, R.G., Swirsky, D. & Hayhoe, F.G. (1986) Principal results of the Medical Research Council's 8th Acute Myeloid Leukaemia trial. Lancet. ii, 1236-1241.
16. Speyer, J.L., Green, M.D., Kramer, E., Rey, M., Sanger, J., Ward, C., Dubin, N., Ferrans, V. Stecy, P., Zeleniuch-Jacquotte, A., Wernz, J., Feit, F., Slater, W., Blum, R. & Muggia, F. (1988) Protective effect of the bispiperaznedione ICRF-187 against doxorubicin-induced cardiotoxicity in women with advanced breast cancer. New England Journal of Medicine, 319, 745-752.
17. Steinherz, L.J., Steinherz, P.G., Tan, C.T., Heller, G. & Murphy, M.L. (1991) Cardiac toxicity 4 to 20 years after completing anthracycline therapy. Journol of the American Medical Association. 266, 1672-1677.
18. Wexler, L.H, Andrich, M.P., Venzon, D., Berg, S.L., Weaver-Mcclure, L., Chen, C.C., Dilsizian, V., Avila, N., Jarosinski, P., Balls, F.M., Poplack, D.G. & Horowite, M.E. (1996) Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. Journal of Clinical Oncology. 14, 362-372.
19. Wheatley, K., Burnett, A., Goldstone, A., Hann, I., Stevens, R., Rees, J. & Gray, R. (1995) A simple, robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the United Kingdom Medical Research Council (MRC) AML1 trial. Blood. 86. (Suppl. 1). 598a (Abstract 2381).
20. Woods, W.G., Kobrinsky, N., Buckley, J.D., Lee, J.W., Sanders, I., Neudorf, S., Gold, S., Barnard, D.R., DeSwarte, J., Dusenbery, K., Kalousek, D., Arthur, D.C. & Lange, B.J. (1996a) Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report From the children's cancer group. Blood. 87, 4979-4989.
21. Woods, W.G., Neudorf, S., Gold, S., Sanders, J., Kubrinsky, D., Barnard, J., DeSwarte, D., Lange, A. & Lange, B.J. (1996b) Aggressive post-remission (REM) chemotherapy is better than autologous bone marrow transplantation (BMT) and allogeneic BMT is superior to both in children with acute myeloid leukemia (AML) Proceedings of the American Society of Clinical Oncology, 15, 368 (Abstract 1091).